Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IRD | OPUS GENETICS INC | $43.07M | -180.20% | -132.30% | -225.02% | 2,567.50% | 1.68 | 3.24 | 100.00% | -523.40% | -523.40% | ||
| SGMO | SANGAMO THERAPEUTICS INC | $157.30M | -275.30% | -90.10% | -175.73% | -184.00% | 3.46 | 1.13 | 100.00% | -169.40% | -169.74% | ||
| BLUE | BLUEBIRD BIO INC | $34.27M | -656.30% | -45.80% | -157.14% | -46.70% | -15.60 | 0.48 | -6.60% | -287.20% | -260.20% | ||
| SABS | SAB BIOTHERAPEUTICS INC | $16.63M | -84.30% | -59.00% | -93.29% | -79.90% | 0.70 | 2.98 | 100.00% | -2,579.00% | -2,554.95% | ||
| CALC | CALCIMEDICA INC | $26.96M | -100.50% | -65.10% | -85.04% | -138.30% | 0.37 | 5.34 | N/A | N/A | N/A | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $23.76M | -104.90% | -79.20% | -101.45% | -169.60% | 0.25 | 4.98 | N/A | N/A | N/A | ||
| IBIO | IBIO INC | $12.77M | -130.50% | -89.30% | -151.50% | -244.90% | 0.68 | 1.12 | 100.00% | -5,597.90% | -5,537.07% | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $351.31M | -52.80% | -29.70% | -34.46% | -37.80% | 1.01 | 9.24 | -225.60% | -2,642.70% | -2,599.10% | ||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $399.93M | -21.60% | -19.30% | -25.93% | -280.70% | 0.13 | 9.00 | 100.00% | -79.90% | -84.00% | ||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.85M | -87.90% | -67.80% | -109.60% | -246.30% | 0.39 | 4.44 | -215.50% | -3,225.00% | -3,349.71% | ||
| ATXS | ASTRIA THERAPEUTICS INC | $238.72M | -27.40% | -26.00% | -29.16% | -37.50% | 0.07 | 17.49 | N/A | N/A | N/A | ||
| VIGL | VIGIL NEUROSCIENCE INC | $112.95M | -111.70% | -74.70% | -113.01% | -148.00% | 0.65 | 2.97 | N/A | N/A | N/A | ||
| EVAX | EVAXION BIOTECH A | $2.09M | N/A | -83.30% | -101.42% | -70.50% | -8.56 | 2.01 | 100.00% | -316.00% | -246.17% | ||
| OTLK | OUTLOOK THERAPEUTICS INC | $48.99M | N/A | -123.20% | 140.00% | -6,077.60% | -1.34 | 0.33 | N/A | N/A | N/A | ||
| RNXT | RENOVORX INC | $38.74M | -156.10% | -100.90% | -148.14% | 973.30% | 0.81 | 4.10 | 100.00% | -20,497.70% | -21,390.70% | ||
| VIR | VIR BIOTECHNOLOGY INC | $702.94M | -47.50% | -39.30% | -49.47% | -52.60% | 0.25 | 6.79 | 96.20% | -2,769.00% | -2,775.77% | ||
| LFWD | LIFEWARD LTD | $14.56M | -89.00% | -63.40% | -142.63% | -372.10% | 0.62 | 2.08 | 32.00% | -112.80% | -112.61% | ||
| GEVO | GEVO INC | $277.95M | -15.30% | -12.90% | -13.36% | -21.70% | 0.19 | 8.36 | 29.00% | -464.90% | -441.98% | ||
| AZUL | AZUL SA | $74.47M | N/A | -39.10% | -79.93% | -11.70% | -1.86 | 0.27 | 57.40% | -46.90% | -20.19% | ||
| CTSO | CYTOSORBENTS CORP | $54.44M | -138.70% | -42.40% | -55.96% | -41.40% | 3.27 | 2.20 | 70.60% | -58.20% | -59.03% | ||
| GOSS | GOSSAMER BIO INC | $252.22M | -117.80% | -17.40% | -16.32% | -10.20% | 9.69 | 6.89 | 100.00% | -49.30% | -38.46% | ||
| IBRX | IMMUNITYBIO INC | $1.77B | N/A | -103.90% | -79.04% | -23.20% | -1.78 | 3.36 | 100.00% | -2,804.80% | -1,758.13% | ||
| IMAB | I-MAB | $71.76M | -10.10% | -7.70% | -10.88% | -31.30% | 0.06 | 20.90 | N/A | N/A | N/A | ||
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | $75.52M | -133.30% | -24.80% | -35.21% | -50.50% | 19.76 | 2.92 | 100.00% | -39.80% | -35.89% | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $100.12M | -30.70% | -21.80% | -20.83% | -28.20% | 0.08 | 20.69 | N/A | N/A | N/A | ||
| TIL | INSTIL BIO INC | $86.34M | -39.70% | -26.10% | -25.48% | -18.60% | 0.56 | 15.76 | N/A | N/A | N/A | ||
| CLSD | CLEARSIDE BIOMEDICAL INC | $66.27M | N/A | -107.00% | -168.96% | -64.20% | -1.65 | 4.44 | 91.00% | -2,064.40% | -2,064.42% | ||
| VERV | VERVE THERAPEUTICS INC | $375.61M | -37.30% | -29.00% | -32.81% | -35.60% | 0.31 | 12.65 | 100.00% | -614.60% | -613.51% | ||
| PYXS | PYXIS ONCOLOGY INC | $65.90M | -49.20% | -39.60% | -56.99% | -50.40% | 0.30 | 7.49 | 97.10% | -478.90% | -492.35% | ||
| ADCT | ADC THERAPEUTICS SA | $125.84M | N/A | -46.70% | -44.50% | -83.80% | -2.59 | 3.82 | 91.60% | -222.80% | -151.71% | ||
| TARA | PROTARA THERAPEUTICS INC | $125.01M | -36.40% | -33.30% | -28.11% | -133.30% | 0.06 | 18.03 | N/A | N/A | N/A | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $314.33M | -48.30% | -43.20% | -31.64% | -60.50% | 0.10 | 10.50 | N/A | N/A | N/A | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $753.09M | -64.90% | -56.10% | -58.78% | -85.00% | 0.14 | 9.19 | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.